Reduced DNA repair response of cells from carcinogen-induced rat liver altered foci exposed to chemical carcinogens in culture. 1985

H Mori, and S Sugie, and F Ohbayashi, and H Shima, and N Yoshimi, and M Takahashi, and G M Williams

Cells were cultured from rat livers containing enzyme-altered foci induced by N-2-fluorenylacetamide and the level of DNA repair synthesis in response to several carcinogens was compared in gamma-glutamyl transpeptidase-positive foci cells and in enzyme-negative hepatocytes from the same livers. The level of unscheduled DNA synthesis elicited in foci cells by either the activation-dependent carcinogens N-2-fluorenylacetamide and diethylnitrosamine or the activation-independent carcinogens N-methyl-N'-nitro-N-nitrosoguanidine and 1-methyl-1-nitrosourea was significantly lower than that in hepatocytes. The results suggest that the repair of DNA damage by these altered cells is abnormal.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008769 Methylnitronitrosoguanidine A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties. Methylnitrosonitroguanidine,Nitrosomethylnitroguanidine,Nitrosonitromethylguanidine,MNNG,N-Methyl-N'-nitro-N-nitrosoguanidine,N Methyl N' nitro N nitrosoguanidine
D011912 Rats, Inbred ACI An inbred strain of rat that is widely used in BIOMEDICAL RESEARCH. Applications include the study of spontaneous NEOPLASMS; CHRONIC KIDNEY DISEASES, and CONGENITAL ABNORMALITIES. Rats, Inbred A x C 9935 Irish,Rats, ACI,ACI Rat,ACI Rat, Inbred,ACI Rats,ACI Rats, Inbred,Inbred ACI Rat,Inbred ACI Rats,Rat, ACI,Rat, Inbred ACI
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D005723 gamma-Glutamyltransferase An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid. GGTP,Glutamyl Transpeptidase,gammaglutamyltransferase,gamma-Glutamyl Transpeptidase,Transpeptidase, Glutamyl,Transpeptidase, gamma-Glutamyl,gamma Glutamyl Transpeptidase,gamma Glutamyltransferase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015073 2-Acetylaminofluorene A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines. 2-Acetamidofluorene,Fluoren-2-ylacetamide,2-AAF,2-Fluorenylacetamide,AAF, Aminofluorene,Acetylaminofluorene,N-2-Fluorenylacetamide,N-Acetyl-2-Aminofluorene,2 Acetamidofluorene,2 Acetylaminofluorene,2 Fluorenylacetamide,Aminofluorene AAF,Fluoren 2 ylacetamide,N 2 Fluorenylacetamide,N Acetyl 2 Aminofluorene

Related Publications

H Mori, and S Sugie, and F Ohbayashi, and H Shima, and N Yoshimi, and M Takahashi, and G M Williams
March 1976, Cancer letters,
H Mori, and S Sugie, and F Ohbayashi, and H Shima, and N Yoshimi, and M Takahashi, and G M Williams
January 1989, Research communications in chemical pathology and pharmacology,
H Mori, and S Sugie, and F Ohbayashi, and H Shima, and N Yoshimi, and M Takahashi, and G M Williams
August 1982, Experimental and molecular pathology,
H Mori, and S Sugie, and F Ohbayashi, and H Shima, and N Yoshimi, and M Takahashi, and G M Williams
February 1991, Hepatology (Baltimore, Md.),
H Mori, and S Sugie, and F Ohbayashi, and H Shima, and N Yoshimi, and M Takahashi, and G M Williams
January 1989, Toxicologic pathology,
H Mori, and S Sugie, and F Ohbayashi, and H Shima, and N Yoshimi, and M Takahashi, and G M Williams
April 1987, Carcinogenesis,
H Mori, and S Sugie, and F Ohbayashi, and H Shima, and N Yoshimi, and M Takahashi, and G M Williams
April 1996, Biochemistry and molecular biology international,
H Mori, and S Sugie, and F Ohbayashi, and H Shima, and N Yoshimi, and M Takahashi, and G M Williams
January 1990, Experimental pathology,
H Mori, and S Sugie, and F Ohbayashi, and H Shima, and N Yoshimi, and M Takahashi, and G M Williams
December 1982, Cancer research,
H Mori, and S Sugie, and F Ohbayashi, and H Shima, and N Yoshimi, and M Takahashi, and G M Williams
August 1990, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!